Novel strategies of Raman imaging for monitoring the therapeutic bene fit of temozolomide in glioblastoma
Open Access
- 5 October 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Molecular Structure
- Vol. 1217, 128381
- https://doi.org/10.1016/j.molstruc.2020.128381
Abstract
No abstract availableFunding Information
- National Science Center of Poland (UMO-2017/27/N/NZ3/02350, UMO-015/19/B/ST4/01878)
This publication has 34 references indexed in Scilit:
- Retinoids in the treatment of glioma: a new perspectiveCancer Management and Research, 2012
- Cross Talk between Signaling and Vitamin A Transport by the Retinol-Binding Protein Receptor STRA6Molecular and Cellular Biology, 2012
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Triazene compounds: Mechanism of action and related DNA repair systemsPharmacological Research, 2007
- MGMT hypermethylation: A prognostic foe, a predictive friendDNA Repair, 2007
- Enhanced proapoptotic effects of tumor necrosis factor–related apoptosis-inducing ligand on temozolomide-resistant glioma cellsJournal of Neurosurgery, 2007
- Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Recursive Partitioning Analysis of the EORTC 26981/22981-NCIC CE3 Phase III Randomized TrialJournal of Clinical Oncology, 2006
- MGMTGene Silencing and Benefit from Temozolomide in GlioblastomaThe New England Journal of Medicine, 2005
- Cellular retinol-binding protein-I inhibits PI3K/Akt signaling through a retinoic acid receptor-dependent mechanism that regulates p85–p110 heterodimerizationOncogene, 2004
- Chromosomal localization of human O6-methylguanine-DNA methyltransferase (MGMT) gene by in situ hybridizationMutagenesis, 1992